Deficits in plasma oestradiol measurement in studies and management of breast cancer
about
The challenge of measuring circulating estradiol at low concentrationsAnalysis of estrogens in serum and plasma from postmenopausal women: past present, and futureLC-MS analysis of estradiol in human serum and endometrial tissue: Comparison of electrospray ionization, atmospheric pressure chemical ionization and atmospheric pressure photoionization.Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.Hetereogeneity of dose and time effects of estrogen on neuron-specific neuronal protein and phosphorylated cyclic AMP response element-binding protein in the hippocampus of ovariectomized ratsDoes estrogen play a role in response to adjuvant bone-targeted therapies?Dehydroepiandrosterone, androgens and the mammary gland.Challenges to the measurement of estradiol: an endocrine society position statementHormonal therapies in young breast cancer patients: when, what and for how long?Predictors of recovery of ovarian function during aromatase inhibitor therapy.Liquid chromatography/mass spectrometry of pre-ionized Girard P derivatives for quantifying estrone and its metabolites in serum from postmenopausal womenTopical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.Challenges and improvements in testosterone and estradiol testing.Combined effects of endogenous sex hormone levels and mammographic density on postmenopausal breast cancer risk: results from the Breakthrough Generations StudyReceptor conversion in metastatic breast cancer: a prognosticator of survivalManagement of vaginal dryness and dyspareunia in estrogen sensitive cancer patients.New insights into endocrine therapy for young women with breast cancer.Clinical implications of estrone sulfate measurement in laboratory medicine.Low-dose vaginal estrogens or vaginal moisturizer in breast cancer survivors with urogenital atrophy: a preliminary study.Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane.Substantial discrepancies in 17beta-oestradiol concentrations obtained with three different commercial direct radioimmunoassay kits in rat sera.Oestrogen Receptor-α binds the FOXP3 promoter and modulates regulatory T-cell function in human cervical cancer.
P2860
Q24797684-F1C94E9B-693B-4FE1-817A-359B67AF39A1Q30432877-C87B9FD2-8126-434E-96C5-D7AF10A7D8BCQ33459365-093711CF-058B-4A90-B882-85E6795FD514Q33710960-A52B22CE-5550-43DB-81D7-5DCC5F20D880Q34798901-F480B984-FD11-4BF8-B96F-1B97A743DD64Q36491529-928A4A80-FC95-42CF-B69D-A5ACC5B81DD6Q36533630-49ED2041-2F6F-4F99-A069-4BBE4530B882Q36736507-216C8CCF-9A3E-460C-834B-0C5AB5447A4AQ36963393-617D657C-4176-4FE9-8E93-B73B0694C9D5Q37032856-A3CD3EED-BD3C-481A-8191-3E2D2E8DD027Q37066145-91AEA51D-DCA3-4D32-BBA9-8C072BB494C4Q37360543-3ED1E783-8021-4B09-9DFF-F37F14B7F995Q37639185-D729888F-12AA-4B81-96D5-7E26BD87593CQ37681743-C416B82F-DBB6-409A-9A24-899F6861CBC5Q37687736-55663BAE-B0F2-45EE-AABA-06A42F04A167Q37992713-7E4CEDF5-CEDD-46D3-9587-0C1C525AD26CQ38535371-2984A149-9DEF-4B15-8097-05E1FA349AE1Q39037694-409C7A87-71C5-44AB-88C4-D17AB9B9869BQ43145015-01795339-6B8C-4656-8ABB-BEFAB7EC1698Q44437527-9AB051AB-BBFB-4619-BA5C-495F7BBA2664Q46486475-85A8B1E9-0F16-4353-960A-4CBD1F03493CQ47129920-89204421-6AA5-4F52-9249-9EAA0BB1B8AE
P2860
Deficits in plasma oestradiol measurement in studies and management of breast cancer
description
2004 nî lūn-bûn
@nan
2004 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@ast
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@en
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@nl
type
label
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@ast
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@en
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@nl
prefLabel
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@ast
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@en
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@nl
P2860
P921
P356
P1476
Deficits in plasma oestradiol measurement in studies and management of breast cancer
@en
P2093
Elizabeth Folkerd
P2860
P2888
P356
10.1186/BCR960
P407
P577
2004-10-28T00:00:00Z
P5875
P6179
1009804824